Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


Alios BioPharma 

260 East Grand Avenue
2nd Floor
South San Francisco  California  94080  U.S.A.
Phone: 650-635-5500 Fax: 650-872-0584


 Company News
South San Francisco's Alios BioPharma Raises $41 Million In Series B Financing 4/7/2014 10:57:52 AM
Alios BioPharma Reports Significant Progress With Its Clinical Program For AL-8176, Its Nucleoside Analog For The Treatment Of Respiratory Syncytial Virus (RSV) 1/13/2014 9:30:08 AM
Alios BioPharma Presented Data on Its First-in-Class Anti-Respiratory Syncytial Virus (RSV) Nucleoside Analogs at the 8th Annual Respiratory Syncytial Virus Symposium 10/1/2012 10:07:39 AM
Vertex Pharmaceuticals (MA) (VRTX) Vows to Fight on With Alios BioPharma Drugs in High-Stakes Hepatitis C Race 1/24/2012 7:24:04 AM
Vertex Pharmaceuticals (MA) (VRTX) and Alios BioPharma Begin Clinical Studies of Nucleotide Drug Candidates ALS-2200 and ALS-2158 for the Treatment of Hepatitis C 12/9/2011 6:51:43 AM
Alios BioPharma Signs Flu Treatment Deal with University of Hong Kong 10/31/2011 2:08:32 PM
U.S. Biotech Alios BioPharma and Versitech Ltd. Announce Exclusive Worldwide Licensing Agreement for Influenza Technology 10/31/2011 8:32:30 AM
Vertex Pharmaceuticals (MA) (VRTX) in Licensing Pact Potentially Worth $1.5 Billion With Alios BioPharma to Expand Hepatitis Pipeline 6/13/2011 7:59:34 AM
Alios BioPharma Names Carol L. Brosgart, M.D., as Chief Medical Officer 2/7/2011 8:31:04 AM
Alios BioPharma Issued Broad U.S. Patent for Glyco-Engineered Interferons 10/16/2009 8:39:33 AM